A
Alexisbio
alexisbio.com
Website unreachable since Oct 21, 2026
The startup operates a clinical-stage cell therapy platform that engineers personalized cells for the transplantation of various structures, including bone grafts and blood vessels. This technology provides regenerative medicine solutions aimed at treating both common and rare diseases.
Traction –/10
Boston, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$13.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a clinical-stage cell therapy platform that engineers personalized cells for the transplantation of various structures, including bone grafts and blood vessels. This technology provides regenerative medicine solutions aimed at treating both common and rare diseases.